Parkinson’s disease (PD) is a long-term neurodegenerative disorder of the central nervous system whose symptoms generally come on slowly over time, mainly affecting the motor system. The most common genetic cause of PD is a mutation in the LRRK2 loci, however, this gene’s normal physiological role in the brain is unclear. Now, a study from researchers at the National Institutes of Health shows the LRRK gene is necessary for the survival of dopamine-containing neurons in the brain, the cells most affected by Parkinson’s. The team states their findings could alter the design of treatments against the disease. The study published in the journal Neuron.
Previous studies show LRRK2 is found along with a closely related protein, LRRK1, in the brain. A mutation in LRRK2 alone can eventually produce Parkinson’s disease symptoms and brain pathology in humans as they age. In mice, however, LRRK2 loss or mutation does not lead to the death of dopamine-producing neurons, possibly because LRRK1 plays a complementary or compensatory role during the relatively short, two-year mouse lifespan. The current study investigates the roles of these closely related proteins in brain function using animal models.
The current study utilizes mice lacking both LRRK1 and LRRK2 proteins to observe a loss of dopamine-containing neurons in areas of the brain consistent with PD. Results show a buildup of a protein called α-synuclein, a hallmark of Parkinson’s, in the affected dopamine brain cells. Data findings show inactivation of LRRK2 and its functional homolog LRRK1 results in earlier mortality and age-dependent, selective neurodegeneration.
Results show LRRK is critical for the survival of the populations of neurons affected by Parkinson’s disease. Data findings show while the deletion of both LRRK1 and LRRK2 did not affect overall brain size or cells in such areas of the brain as the cerebral cortex and cerebellum, the mice showed other significant effects such as a decrease in body weight and a lifespan of only 15 to 16 months.
The team surmises their study reveals an essential role of LRRK in the survival of dopamine neurons and in the regulation of the dead cell and debris clearance pathway in the aging brain. For the future, the researchers state they are now developing mice that have LRRK1 and 2 removed only in the dopamine-containing neurons of the brain.
Get Healthinnovations delivered to your inbox:
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.